For many people who contracted COVID-19 during the pandemic, recovery was assumed to indicate a return to full health once initial symptoms subsided. Yet a growing body of evidence shows that for some, the virus leaves behind lingering effects that are not immediately apparent, even when standard tests suggest the lungs have healed. This disconnect between feeling well and experiencing unexpected health complications has become a focal point in understanding the long-term impact of SARS-CoV-2 infection.
One patient’s account, widely shared in Chilean media, captured this experience succinctly: “Aparentemente estaba bien de los pulmones; después de que me dio Covid resultó que no.” Translated as “Apparently I was fine in the lungs; after I got Covid, it turned out I wasn’t,” the statement reflects a growing recognition among clinicians and researchers that respiratory recovery does not always equate to systemic wellness following COVID-19.
Medical professionals now refer to this constellation of persistent symptoms as Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC). According to the World Health Organization, Long COVID occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually three months from the onset of COVID-19, with symptoms lasting at least two months and cannot be explained by an alternative diagnosis.What is Long COVID?
The condition can affect multiple organ systems, with fatigue, shortness of breath, cognitive dysfunction (often described as “brain fog”), and post-exertional malaise being among the most commonly reported symptoms. Notably, these issues can arise even in individuals who had mild or asymptomatic initial infections and showed normal results on lung imaging or pulmonary function tests shortly after recovery.
Understanding the Disconnect Between Lung Health and Systemic Symptoms
Standard clinical assessments following COVID-19 often focus on respiratory function, using tools like spirometry, chest X-rays, or CT scans to evaluate lung recovery. When these tests return normal results, patients may be told their lungs have healed — a conclusion that can be both reassuring, and misleading.
Research indicates that SARS-CoV-2 can trigger widespread inflammation, endothelial dysfunction, and autonomic nervous system dysregulation, which may persist despite structural healing of lung tissue. A study published in The Lancet Respiratory Medicine found that among hospitalized COVID-19 patients, over 60% reported at least one lingering symptom six months post-infection, with fatigue and muscle weakness being predominant — even when lung function appeared preserved.Six-month consequences of COVID-19 in patients discharged from hospital: a cohort study
emerging evidence suggests that viral remnants or immune system dysregulation may contribute to ongoing symptoms. The National Institutes of Health’s RECOVER Initiative has identified potential biological drivers of Long COVID, including persistent viral reservoirs, autoimmunity, and chronic inflammation, which may not be detectable through routine pulmonary evaluations.NIH RECOVER Initiative
Who Is at Risk for Long COVID?
While anyone infected with SARS-CoV-2 can develop Long COVID, certain factors may increase susceptibility. Data from the U.S. Centers for Disease Control and Prevention indicate that Long COVID is more commonly reported among women, older adults, and individuals who experienced severe initial illness. However, a significant number of cases occur in younger, previously healthy people who had mild infections.Long COVID or Post-COVID Conditions
Vaccination has been shown to reduce the risk of developing Long COVID. A systematic review published in JAMA Internal Medicine found that individuals who received two doses of an mRNA vaccine prior to infection had approximately a 50% lower risk of reporting Long COVID symptoms compared to unvaccinated individuals.Association Between Vaccination and Long COVID: A Systematic Review
Reinfection also raises concerns, as each subsequent infection carries an additional risk of triggering or worsening Long COVID symptoms. Public health experts emphasize that minimizing exposure through updated vaccinations, masking in high-risk settings, and early treatment remain key strategies in reducing the burden of post-COVID conditions.
Diagnosis and Management Challenges
Diagnosing Long COVID remains challenging due to the wide variability of symptoms and the absence of a single definitive test. Clinicians typically rely on a process of exclusion, ruling out other potential causes while assessing the temporal relationship between symptoms and prior SARS-CoV-2 infection.
Specialized post-COVID clinics have emerged in many countries to provide multidisciplinary care, often involving pulmonologists, cardiologists, neurologists, and rehabilitation specialists. Treatment approaches are largely symptomatic and supportive, focusing on pacing strategies for post-exertional malaise, cognitive rehabilitation, and graded exercise therapy when appropriate.
The WHO recommends that healthcare systems integrate Long COVID into routine care pathways, ensuring access to disability benefits, workplace accommodations, and mental health support for affected individuals.A clinical case definition of post COVID-19 condition by a Delphi consensus
What This Means for Public Health
The phenomenon described by the patient in Chile — feeling lung-recovered yet experiencing unexplained health issues — underscores a critical gap in how societies assess recovery from infectious diseases. Relying solely on organ-specific diagnostics may overlook systemic consequences that affect quality of life, work capacity, and long-term well-being.
As of early 2026, global surveillance efforts continue to track the prevalence and impact of Long COVID. The WHO estimates that tens of millions of people worldwide have experienced post-COVID conditions, with significant implications for healthcare systems, labor markets, and social support networks.Post COVID-19 condition
Ongoing research into biomarkers, therapeutic interventions, and prevention strategies offers hope for better understanding and management of this complex condition. Meanwhile, patient narratives like the one shared in Chilean media serve as vital reminders that recovery is not always linear — and that listening to lived experience remains essential in shaping effective public health responses.
For the latest official guidance on Long COVID symptoms, diagnosis, and support resources, individuals are encouraged to consult their national public health agencies or visit trusted sources such as the World Health Organization and the U.S. Centers for Disease Control and Prevention.
Have you or someone you know experienced lingering health issues after a COVID-19 infection, even when initial tests appeared normal? Sharing your story can help raise awareness and improve care for others navigating similar challenges. Consider commenting below or sharing this article to support informed conversations about post-pandemic health.